At a glance
ClinicalIndex Comparison RecordN/ACompleted· 317 enrolled
Drug / intervention
Continuous Glucose Monitoringdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of Updated Continuous Glucose Monitoring (CGM) Form Factor in Adults, Adolescents and Pediatrics
In Brief
A clinical study evaluating Continuous Glucose Monitoring for Type 1 Diabetes Mellitus and Type 2 Diabetes Mellitus. Completed, enrolled 317 participants across 18 sites in 2 countries.
Detailed Summary
The purpose of this study is to demonstrate the performance of the Disposable Sensor (DS5) in subjects age 2 - 80 years, for the span of 170 hours (7 days).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
CountriesChina, United States
Collaborators--
Timeline
N/ACompletedFinished
202120222023202420252026
First PostedJun 2020
Enrollment StartJul 2020
Primary CompletionApr 2022
TodayJul 2026
First PostedJun 18, 2020
Enrollment StartJul 15, 2020
Primary CompletionApr 12, 2022
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 6.0 years ago
Interventions
Continuous Glucose Monitoringdevice
CGM and frequent sample testing